MedTrace Logo

Guided Bone Regeneration Using Synthetic Membrane

NCT01654627 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2013-08-27

No results posted yet for this study

Summary

The purpose of this study is to examine the safety and usefulness of the Regenecure guided bone regeneration membrane for stimulating bone growth in patients that don't have enough bone for dental implant placement. The study will include 16 patients in each group, 20 non-smokers and 12 smokers, a total of 32 patients will participate in the study.

Conditions

  • Jaw, Edentulous
  • Jaw, Edentulous, Partially

Interventions

DEVICE

Regenecure AMCA GBR Dental Membrane

Patients will undergo Guided Bone Regeneration (GBR) procedure using the Regenecure AMCA GBR Membrane

DEVICE

Geistlich Bio-Gide® collagen membrane

The Geistlich Bio-Gide® collagen membrane, a commercially available product, will be used in 10 patients.

Sponsors & Collaborators

  • RegeneCure, Ltd.

    lead INDUSTRY

Principal Investigators

  • Lior Shapira, PhD · Haddasah Medical Center, Jerusalem Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-04-30
Completion
2015-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654627 on ClinicalTrials.gov